In the balanced crystalloid + 20% albumin group, the SV at the start of the experiment decreased by 17.4% from 81.4 ml/beat at the start of the experiment to 67.2 ml/beat after the end of fluid infusion, which was not statistically significant (p = 0.099; the start of the experiment—the end of controlled hemorrhage p < 0.001; the end of controlled hemorrhage—the start of the resuscitation phase 2 p = 0.001; the start of the resuscitation phase 2—the time of recovery to the initial value of 1M impedance p = 0.347). The gene discussed is ALB; the disease is hemorrhage.